Pulse Biosciences, Inc. PLSE Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s total current liabilities?
- Pulse Biosciences, Inc. (PLSE) reported total current liabilities of $9.8M in Q1 2026.
- How has Pulse Biosciences, Inc.'s total current liabilities changed year-over-year?
- Pulse Biosciences, Inc.'s total current liabilities increased by 26.2% year-over-year, from $7.76M to $9.8M.
- What is the long-term trend for Pulse Biosciences, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s total current liabilities has grown at a 0.9% compound annual growth rate (CAGR), from $7.59M to $7.92M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.